| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.007 |